Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by Gladius Capital Management LP

Gladius Capital Management LP trimmed its position in Phibro Animal Health Co. (NASDAQ:PAHC) by 43.3% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,815 shares of the company’s stock after selling 1,385 shares during the period. Gladius Capital Management LP’s holdings in Phibro Animal Health were worth $30,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of PAHC. Cardinal Capital Management boosted its holdings in Phibro Animal Health by 4.7% in the second quarter. Cardinal Capital Management now owns 56,027 shares of the company’s stock worth $940,000 after purchasing an additional 2,520 shares during the period. CWM LLC increased its holdings in shares of Phibro Animal Health by 89.8% in the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after acquiring an additional 1,035 shares during the period. Jacobs Levy Equity Management Inc. raised its holdings in shares of Phibro Animal Health by 56.0% during the first quarter. Jacobs Levy Equity Management Inc. now owns 79,667 shares of the company’s stock valued at $1,030,000 after buying an additional 28,584 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in Phibro Animal Health by 7.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company’s stock valued at $200,000 after acquiring an additional 1,063 shares in the last quarter. Finally, Acadian Asset Management LLC lifted its holdings in Phibro Animal Health by 32.8% in the first quarter. Acadian Asset Management LLC now owns 675,207 shares of the company’s stock worth $8,726,000 after purchasing an additional 166,776 shares during the period. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Price Performance

PAHC stock opened at $18.05 on Friday. The company has a current ratio of 3.16, a quick ratio of 1.67 and a debt-to-equity ratio of 1.69. The firm has a market capitalization of $731.08 million, a PE ratio of 56.41, a P/E/G ratio of 4.60 and a beta of 0.57. Phibro Animal Health Co. has a one year low of $9.40 and a one year high of $19.55. The firm has a 50-day moving average of $17.72 and a two-hundred day moving average of $15.41.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 4th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, September 4th. This represents a $0.48 dividend on an annualized basis and a yield of 2.66%. Phibro Animal Health’s payout ratio is presently 150.00%.

Analyst Ratings Changes

Separately, Barclays upped their price target on shares of Phibro Animal Health from $10.00 to $13.00 and gave the stock an “underweight” rating in a research note on Friday, May 10th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $14.75.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.